Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hochman

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Bone Marrow Transplantation|May 7, 2024
Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamideIlias Sinanidis, Michael J Hochman, Hua-Ling Tsai, et al.
Leukemia & Lymphoma|March 23, 2021
Effect of post-treatment MRD status on subsequent outcomes according to chemotherapy intensity in acute myeloid leukemia (AML)Michael J Hochman, Megan Othus, Roland B Walter, et al.
Leukemia|July 31, 2023
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classificationMichael J Hochman, Megan Othus, Robert P Hasserjian, et al.
British Journal of Haematology|December 3, 2025
Real-world analysis of CPX-351 in AML-MR: A multicentre study from the MARROW consortiumDaniel T Peters, Deedra Nicolet, Yazan F Madanat, et al.
Circulation|May 20, 1999
Thrombogenic factors and recurrent coronary eventsA J Moss, R E Goldstein, V J Marder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 12, 2025
Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed <i>NPM1</i>-Mutated or <i>KMT2A</i>-Rearranged AMLJoshua F Zeidner, Tara L Lin, Rina Li Welkie, et al.
Haematologica|April 23, 2026
Phase Ib/II trial of anti-CD33 monoclonal antibody BI 836858 and azacitidine in previously untreated older acute myeloid leukemia patients: Beat AML S2 sub-study resultsMichael J Hochman, Amy S Ruppert, Ying Huang, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|April 30, 2022
Canadian Surgery ForumR Fayez, M Roy, S Villeneuve, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Bone Marrow Transplantation|May 7, 2024
Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamideIlias Sinanidis, Michael J Hochman, Hua-Ling Tsai, et al.
Leukemia & Lymphoma|March 23, 2021
Effect of post-treatment MRD status on subsequent outcomes according to chemotherapy intensity in acute myeloid leukemia (AML)Michael J Hochman, Megan Othus, Roland B Walter, et al.
Leukemia|July 31, 2023
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classificationMichael J Hochman, Megan Othus, Robert P Hasserjian, et al.
British Journal of Haematology|December 3, 2025
Real-world analysis of CPX-351 in AML-MR: A multicentre study from the MARROW consortiumDaniel T Peters, Deedra Nicolet, Yazan F Madanat, et al.
Circulation|May 20, 1999
Thrombogenic factors and recurrent coronary eventsA J Moss, R E Goldstein, V J Marder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 12, 2025
Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed <i>NPM1</i>-Mutated or <i>KMT2A</i>-Rearranged AMLJoshua F Zeidner, Tara L Lin, Rina Li Welkie, et al.
Haematologica|April 23, 2026
Phase Ib/II trial of anti-CD33 monoclonal antibody BI 836858 and azacitidine in previously untreated older acute myeloid leukemia patients: Beat AML S2 sub-study resultsMichael J Hochman, Amy S Ruppert, Ying Huang, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|April 30, 2022
Canadian Surgery ForumR Fayez, M Roy, S Villeneuve, et al.
Pageof 11